MedTrace Logo

Recanalization and Stenting for Non-acute Veterbrobasilar Artery Occlusion

NCT01632865 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-01-25

No results posted yet for this study

Summary

To evaluate whether recanalization and stenting for symptomatic subacute and chronic veterbrobasilar artery occlusion is technically feasible, can prevent from recurrent ischemic events and promotes functional recovery of disability.

Conditions

Interventions

DEVICE

stenting

Apollo stent (MicroPort Medical, China),Neuroform stent (Stryker/Boston Scientific, USA) or Wingspan stent (Stryker/Boston Scientific, USA), et al.

Sponsors & Collaborators

  • Henan provincial interventional therapy center

    collaborator UNKNOWN

  • Henan Provincial People's Hospital

    collaborator OTHER

  • Zhengzhou University

    lead OTHER

Principal Investigators

  • Tianxiao Li, MD. PhD · Henan provincial intervention therapy center

  • Ziliang Wang, MD · Henan Provincial People's Hospital

  • Yingkun He, MD. · Henan Provincial People's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01632865 on ClinicalTrials.gov